Oncology Ablation Market Trends, Size & Forecast by 2034

Coverage: By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Ethanol Ablation, Irreversible Electroporesis (IRE), Laser Ablation, Ultrasound Ablation); Types of Cancer (Lung Cancer, Liver Cancer, Breast Cancer, Kidney Cancer, Colorectal Cancer, Prostate Cancer), Impact of covid-19 pandemic., and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00017456
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : April 17, 2026
Oncology Ablation Market Trends, Size & Forecast by 2034
Report Date: April 17, 2026   |   Report Code: TIPRE00017456 Email: sales@theinsightpartners.com

2025 Market Size

US$ 2.18 Bn

Base year value

2034 Forecast

US$ 7.27 Bn

Projected by 2034

CAGR 2026-2034

14.34 %

Growth rate

Addressable Market

US$ 40.68 Bn

(2026-2034)

The global oncology ablation market size is projected to reach US$ 7.27 billion by 2034 from US$ 2.18 billion in 2025. The market is anticipated to register a CAGR of 14.34% during the forecast period 2026-2034.

Oncology Ablation Market Size and Forecasts (2021 - 2034), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Ethanol Ablation, Irreversible Electroporesis (IRE), Laser Ablation, Ultrasound Ablation); Types of Cancer (Lung Cancer, Liver Cancer, Breast Cancer, Kidney Cancer, Colorectal Cancer, Prostate Cancer), Impact of covid-19 pandemic., and Geography (North America, Europe, Asia Pacific, and South and Central America)

Purpose of the Report

The report Oncology Ablation Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Oncology Ablation Market Segmentation Technology

  1. Radiofrequency Ablation
  2. Microwave Ablation
  3. Cryoablation
  4. Ethanol Ablation
  5. Irreversible Electroporesis
  6. Laser Ablation
  7. Ultrasound Ablation

Types of Cancer

  1. Lung Cancer
  2. Liver Cancer
  3. Breast Cancer
  4. Kidney Cancer
  5. Colorectal Cancer
  6. Prostate Cancer

Market Research Highlights

  • Global market for Oncology Ablation was valued at US$ 2.18 Billion in 2025
  • Annual market size is expected to reach US$ 7.27 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 40.68 Billion
  • Market is anticipated to register a CAGR of 14.34% during the forecast period
  • The United States represents a key market, supported by Increasing Incidence of Gynecological Disorders, Innovative Treatments, Research & Development Expenditure, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Diverse Technologies, Expansion of market, Collaborations and partnerships between companies are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including AngioDynamics, Covidien, Boston Scientific, BSD Medical, Galil Medical, STARMed Co., Varian Medical Systems, MedWaves Incorporated, Accuray, APRO KOREA, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Oncology Ablation Market: Strategic Insights

oncology-ablation-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Oncology Ablation Market Growth Drivers

  1. Increasing Incidence of Gynecological Disorders: The market is primarily driven by the increasing prevalence of diseases such endometrial cancer, polycystic ovary syndrome (PCOS), and menorrhagia (heavy menstrual bleeding). For example, there is a significant need for efficient treatment options like endometrial ablation because almost 10 million women in the United States experience menorrhagia each year.
  2. Innovative Treatments: Patients and medical professionals are increasingly favoring less intrusive surgical methods. For women looking for less traumatic procedures with faster recovery times, endometrial ablation provides a non-invasive substitute for hysterectomy. It is anticipated that this tendency will increase the use of endometrial ablation equipment.
  3. Research & Development Expenditure :Global healthcare spending growth makes it possible to invest more effectively in cutting-edge medical equipment and therapies. Healthcare facilities are able to provide more extensive care alternatives, such as endometrial ablation operations, thanks to this financial support.Key actors in the healthcare industry are working together to improve product options and promote innovation. Businesses are forming alliances to expand their market reach and technological prowess, which helps the market as a whole.

Oncology Ablation Market Future Trends

  1. Technological Developments: Procedures are becoming safer and more effective thanks to advancements in ablation technologies like thermal balloon, cryoablation, and radiofrequency. These developments boost therapy effectiveness and enhance patient outcomes, which propels market expansion.Such a factor has assisted the overall market growth in the recent past and is expected to continue a similar trend during the forecast period.
  2. Growing Awareness: Minimally invasive surgical methods are becoming more and more popular among patients and medical professionals. A non-invasive substitute for a hysterectomy, endometrial ablation appeals to women who want less traumatic operations with shorter recovery periods. The use of endometrial ablation devices is anticipated to increase as a result of this trend.
  3. Rising Healthcare Expenditure: Access to cutting-edge medical technologies, such as endometrial ablation devices, is improved by improved healthcare infrastructure, especially in emerging economies. The industry is anticipated to grow as more clinics and hospitals use these technologies.Such a factor has assisted the overall market growth in the recent past and is expected to continue a similar trend during the forecast period.

Oncology Ablation Market Opportunities

  1. Diverse Technologies: Healthcare practitioners now have more treatment options thanks to the advent of new devices that use a variety of technologies, including cryoablation, radiofrequency, and thermal balloon techniques. Recent approvals such as Hologic's NovaSure V5 Global Endometrial Ablation device, for example, offer cutting-edge treatments for abnormal uterine bleeding (AUB) and enhance procedure effectiveness.
  2. Expansion of market:New products frequently have clinical tests to prove their effectiveness and safety. For instance, new radiofrequency ablation devices have demonstrated great success rates in recent research, which gives healthcare providers more confidence to use these technologies. Increased use and acceptance in clinical practice may result from this validation.
  3. Collaborations and partnerships between companies:To remain competitive in the market, businesses are always inventing. Advanced features that increase usability and efficacy, including improved control mechanisms or greater visibility throughout procedures, are frequently incorporated into new product launches. As businesses compete to satisfy changing patient and clinician needs, the market as a whole grows.

Oncology Ablation Market Report Scope

Report Attribute Details
Market size in 2025 US$ 2.18 Billion
Market Size by 2034 US$ 7.27 Billion
Global CAGR (2026 - 2034) 14.34%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Technology
  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • Ethanol Ablation
  • Irreversible Electroporesis
  • Laser Ablation
  • Ultrasound Ablation
By Types of Cancer
  • Lung Cancer
  • Liver Cancer
  • Breast Cancer
  • Kidney Cancer
  • Colorectal Cancer
  • Prostate Cancer
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AngioDynamics
  • Covidien
  • Boston Scientific
  • BSD Medical
  • Galil Medical
  • STARMed Co.
  • Varian Medical Systems
  • MedWaves Incorporated
  • Accuray
  • APRO KOREA

Oncology Ablation Market Players Density: Understanding Its Impact on Business Dynamics

The Oncology Ablation Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

oncology-ablation-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Oncology Ablation Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Oncology Ablation Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

In Europe, the UK held the second largest share in 2025.

The primary opportunity in the oncology ablation market is the increasing demand for minimally invasive cancer treatments.

Prostate cancer segment held the largest share in 2025.

North America held the largest share in 2025 and is expected to retain its dominance during the forecast period

The Oncology Ablation Market is growing at a CAGR of 14.33% from 2026 to 2034

Increasing Incidence of Gynecological Disorders
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA